hipcProject Profile Banner
HIPC Profile
HIPC

@hipcProject

Followers
1K
Following
8K
Media
688
Statuses
5K

This collaborative #openscience data project probes immune systems. Partners include @ImmPortDB. Created by @NIAIDFunding in 2010.

Joined February 2016
Don't wanna be here? Send us removal request.
@hipcProject
HIPC
4 months
0
0
6
@CEIRRNetwork
CEIRRNetwork
10 days
The Clinical Biospecimen Repository just launched on Flu Hub! Access free, high-quality, @NIAIDnews -funded #influenza biospecimens for your research. Explore, request, and advance your scientific #research: https://t.co/yLNAlcx5iY
0
1
1
@ImmunologyAAI
The American Association of Immunologists (AAI)
18 days
🔬 The second abstract period for #IMMUNOLOGY2026™ opens on December 2! Submit your research and share your findings with the top minds in #immunology. Learn more: https://t.co/R7wzXDaf7Y.
0
1
3
@hipcProject
HIPC
1 month
See you all soon 🙂
@ImmPortDB
ImmPort
1 month
Join us during #ImmPortDB's upcoming #webinar to learn more about resources like #ImmuneSpace and how to build a community-specific resource leveraging ImmPort. Date: Thursday, November 13, 2025 Time: 12:00 PM PT (US) / 03:00 PM ET (US) Register today! https://t.co/84IJWxpScj
0
0
1
@ImmPortDB
ImmPort
1 month
There's still time! Join us tomorrow for #ImmPortDB's webinar to learn more about resources like #ImmuneSpace and how to build a community-specific resource leveraging ImmPort. Date: November 13, 2025 Time: 12:00 PM PT / 03:00 PM ET (US) Register today! https://t.co/foVzLihIfV
1
1
1
@ImmunologyAAI
The American Association of Immunologists (AAI)
2 months
Get ready for #IMMUNOLOGY2026™! We're heading to the vibrant city of Boston, MA. Prepare for groundbreaking science, incredible networking, and an unforgettable experience. Don't miss your chance to be part of the #immunology community! Abstracts close October 15. Learn more:
0
3
8
@KeystoneSymp
Keystone Symposia
4 months
Still time to register for Keystone Symposia on Long COVID (PASC), Aug 10–13 in Santa Fe, NM. Join scientific leaders advancing post-infection biology & therapeutics. https://t.co/KGixNxythx 🔗 https://t.co/mRAFxvA8Fz #KSLongCOVID26 @VirusesImmunity @ahandvanish @MichaelPelusoMD
Tweet card summary image
keystonesymposia.org
Join us at the Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes, August 2025, in Santa Fe, with field leaders!
3
5
29
@PlzSolveCFS
Solve ME/CFS Initiative
4 months
Last week, we hosted @VirusesImmunity to discuss her Catalyst Award-winning study, “Probing Functional Autoantibodies in Patients with #MECFS." She shared how her work lays the groundwork for targeted treatment & advancing diagnostic tools. Watch here: https://t.co/43CpYSc4ms
0
47
137
@ImmunityCP
Immunity
5 months
Online now: Asynchronous aging and turnover of human circulating and tissue-resident memory T cells across sites
0
7
32
@hipcProject
HIPC
4 months
3 of our recent studies deal with risk for death in #COVID19. Two from @FrontMedicine 1. https://t.co/8xgmSoxUhH 2. https://t.co/8xgmSoxUhH One from @JCI_insight https://t.co/6Rzsev5IYw All part of the IMPACC collaboration. See some collaborators on map.
0
0
2
@PrecVaccines
Precision Vaccines Program
5 months
New study out in @JCI_insight! @PrecVaccines members @levy_o, @JoannDArce, Al Ozonoff, and #IMPACC collaborators show the MICBG406A gene variant may protect against severe #COVID19 and viral lung injury by lowering #inflammation and risk of critical illness. #PrecVaccinesNetwork
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
MHC class I polypeptide-related sequence B (MICB) is a ligand for NKG2D. We have shown NK cells are central to lung transplant acute lung injury (ALI) via NKG2D activation, and increased MICB in...
0
3
3
@hipcProject
HIPC
5 months
More insights from #IMPACC collaboration, including a polymorphism that might be protective, in this online release. #sarscov2 Authors include: @florian_krammer @Rouphael_N @levy_o @eliashaddad @VivianaSimonLab @skleinstein @bpeters + https://t.co/6Rzsev5IYw
0
2
7
@DonnaFarber3
Donna Farber
5 months
Our study on human T cell aging across blood, lymphoid and mucosal tissues reveals continuous turnover across sites with longer-lived cells in spleen and tissue resident memory T cells protected from immunosenescence. with Yates lab
Tweet card summary image
cell.com
Human memory T cells persist in tissues as circulating and tissue-resident populations. Lam et al. reveal asynchronous aging of T cells across sites and subsets. Splenic memory T cells are longer-l...
2
20
107
@PrecVaccines
Precision Vaccines Program
5 months
@levy_o was quoted by @NBCNews in this article discussing how #COVID19 cases are on the rise this summer. Vulnerable individuals, including elders and those with #immunocompromised immune systems or #chronicdisease should ask their doctors for a COVID-19 vaccine booster ahead of
Tweet card summary image
nbcnews.com
The uptick in cases, caused by a variant of the virus nicknamed "razor blade throat," comes as many Americans have likely gone a year or longer without Covid shots.
0
2
2
@ImmunologyAAI
The American Association of Immunologists (AAI)
5 months
AAI President Ulrich H. von Andrian (Harvard Medical School, Ragon Institute, & MIT) opened the 2025 AAI Advanced Course in Immunology with "Anatomy of the Immune Response," highlighting a unique challenge: unlike other organs, the immune system lacks a defined anatomic location.
0
2
7
@VirusesImmunity
Prof. Akiko Iwasaki
5 months
V. excited to join the SPEAR (Spike Protein Elimination and Recovery) team with @MichaelPelusoMD @microbeminded2 @PutrinoLab @Invivyd to study whether broadly neutralizing mAb can treat Long COVID and post-vaccination syndrome subset driven by persistent spike protein.
investors.invivyd.com
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the...
32
151
647
@hipcProject
HIPC
5 months
So great to see this paper published. Congrats to our collaborators. #IMPACC
@PrecVaccines
Precision Vaccines Program
5 months
Out now in @JCI_insight! #IMPACC network members, including @levy_o, @JoannDArce, Al Ozonoff, and more, found that participants with a high-affinity CD16A gene variant may have reduced risk of severe #COVID19 potentially informing future treatments or #prevention strategies
0
0
4
@hipcProject
HIPC
5 months
Our collaborators unpacked a CD16 #polymorphism associated with #severe #covid19 Authors include: @skleinstein @bpeters @Rouphael_N @SesmaLab @JoannDArce @VivianaSimonLab Bali Pulendran, Mark Davis, Elias Haddad, Al Shaw, Elaine Reed https://t.co/5e1RRWDybj
0
3
6
@hipcProject
HIPC
5 months
Thanks to our collaborator @MiriamMerad for sharing this reminder about #IUIS2025
@iuis_online
International Union of Immunological Societies
5 months
⏳ 1 month until Vienna lights up with #immunology! At #IUIS2025, you’ll swap ideas, spark collaborations & dive into breakthrough science. Plus, savor a slice of Viennese culture ☕ Your badge is waiting: https://t.co/2u2uRU25fd #GlobalImmunology #RoadToVienna
0
0
0